Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics
- 1 March 1994
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 38 (3) , 494-498
- https://doi.org/10.1128/aac.38.3.494
Abstract
The susceptibility of 173 TEM-1-producing isolates of Escherichia coli was assessed by determination of MICs by the agar dilution method. MICs of amoxicillin, mezlocillin, cephaloridine, and, to a smaller extent, amoxicillin-clavulanic acid (but not cephalexin, cefuroxime, cefotaxime, ceftazidime, or imipenem) were higher for isolates that produced large amounts of beta-lactamase than for isolates that produced smaller amounts. The effect of fixed concentrations of clavulanic acid on resistance to amoxicillin was assessed for 34 selected TEM-1-producing isolates. Low concentrations of the inhibitor (0.5 to 1 microgram/ml) reduced the amoxicillin MICs substantially for almost all the isolates, although the reductions were not sufficient to render any of the isolates amoxicillin susceptible. Higher concentrations of clavulanic acid had progressively greater effects on amoxicillin MICs, but even at 8 micrograms/ml some of the isolates with high beta-lactamase activities remained resistant or only moderately susceptible to amoxicillin. All the isolates were inhibited by clavulanic acid (in the absence of amoxicillin) at concentrations of 16 to 32 micrograms/ml. TEM-1 beta-lactamase activity was inhibited in vitro by clavulanic acid, but not totally, with approximately 2% of the initial activity remaining at 2 micrograms/ml and 0.4% remaining at 8 micrograms/ml. These findings suggest that the amount of beta-lactamase activity is a major determinant of the degree of resistance to several beta-lactam antibiotics and can make the difference between susceptibility and resistance to some compounds, notably the combination of amoxicillin with clavulanic acid.Keywords
This publication has 19 references indexed in Scilit:
- Selection of variants of the TEM-1 β lactamase, encoded by a plasmid of clinical origin, with increased resistance to β-lactamase inhibitorsJournal of Antimicrobial Chemotherapy, 1993
- Prevalence of resistance to β-lactam antibiotics in Escherichia coli isolated from blood from 1969–1991Journal of Antimicrobial Chemotherapy, 1992
- -Lactamases of Gram-Negative Bacteria: New Challenges for New DrugsClinical Infectious Diseases, 1992
- Activity of clavulanate combinations against TEM-1 β-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989Journal of Antimicrobial Chemotherapy, 1991
- Factors determining resistance to β-lactam combined with β-lactamase inhibitors in Escherichia coliJournal of Antimicrobial Chemotherapy, 1991
- Hyperproduction of TEM-1 β-lactamase by Escherichia coli strainsJournal of Antimicrobial Chemotherapy, 1989
- Synergistic effect of dosage and bacterial inoculum in TEM-1 mediated antibiotic resistanceEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion testsAntimicrobial Agents and Chemotherapy, 1988
- AMOXYCILLIN/CLAVULANATE RESISTANT ESCHERICHIA COLIThe Lancet, 1988
- AMOXYCILLIN/CLAVULANATE RESISTANT ESCHERICHIA COLIThe Lancet, 1988